Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2025 Jun 27;27(1):46.
doi: 10.1007/s11894-025-00998-0.

A Guide Through the Tunnel: Updates in the Approach to Classification and Management of Perianal Fistulizing Crohn's Disease

WonKyung J Cho  1 , Serre-Yu Wong  2
Affiliations
Review

A Guide Through the Tunnel: Updates in the Approach to Classification and Management of Perianal Fistulizing Crohn's Disease

WonKyung J Cho et al. Curr Gastroenterol Rep. .

Abstract

Purpose of review: Perianal fistulizing Crohn's disease (PFCD) is a severe and debilitating phenotype of Crohn's disease that presents significant clinical and therapeutic challenges. This review aims to outline a practical approach to classification and management, emphasizing the utility of the TOpClass system.

Recent findings: The TOpClass classification incorporates clinical and anatomic characteristics to assess severity, treatment options, and patient-clinician goals. Post-hoc analyses from clinical trials for the Janus kinase inhibitor Upadacitinib and emerging data on IL-23 receptor antagonists suggest potential roles beyond anti-TNFs, while the broader use of mesenchymal stem cell therapy remains limited due to inconsistent efficacy. Fistula conditioning with curettage and internal opening closure-an underutilized technique-alongside adjunctive therapies such as hyperbaric oxygen therapy (HBOT), has shown promise in promoting wound healing in select patients. The TOpClass classification, by integrating patient-centered factors and multidisciplinary management, offers a comprehensive and adaptable framework for PFCD, addressing key gaps in treatment planning, standardization, and research. The classification will enable tailored, evidence-based care across the disease spectrum.

Keywords: Crohn’s disease; Perianal fistula; Perianal fistulizing Crohn’s disease; TOpClass classification.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing Interests: Author SYW reports research contract with Takeda/Trinetx; advisory board - Bristol Myers Squibb; and support - Eli Lilly and Company.

References

    1. Panes J, Rimola J. Perianal fistulizing crohn’s disease: pathogenesis, diagnosis and therapy. Nat Rev Gastroenterol Hepatol. 2017;14(11):652–64. - PubMed - DOI
    1. Tsai L, McCurdy JD, Ma C, Jairath V, Singh S. Epidemiology and natural history of perianal crohn’s disease: A systematic review and Meta-Analysis of Population-Based cohorts. Inflamm Bowel Dis. 2022;28(10):1477–84. - PubMed - DOI
    1. Park KT, Ehrlich OG, Allen JI, Meadows P, Szigethy EM, Henrichsen K, et al. The cost of inflammatory bowel disease: an initiative from the crohn’s & colitis foundation. Inflamm Bowel Dis. 2020;26(1):1–10. - PubMed - DOI
    1. Burisch J, Zhao M, Odes S, De Cruz P, Vermeire S, Bernstein CN, et al. The cost of inflammatory bowel disease in high-income settings: a lancet gastroenterology & hepatology commission. Lancet Gastroenterol Hepatol. 2023;8(5):458–92. - PubMed - DOI
    1. American Gastroenterological Association Clinical Practice C. American gastroenterological association medical position statement: perianal crohn’s disease. Gastroenterology. 2003;125(5):1503–7.

LinkOut - more resources